Patents Held

Dr. Rowe is the inventor of several treatments and therapies for various neurological conditions. Currently, he holds the following patents:

1. Rowe, V., Use of Regularly Scheduled High Dose Intravenous Methotrexate Therapy, with Interim Administration of Immunomodulatory Agents, to Treat Multiple Sclerosis and Other Diseases of the Central Nervous System. (US Patent 6,903,100 B2; 2005)
2. Rowe, V., Compositions Useful for Reducing Nephrotoxicity and Methods of Use Thereof. (US Patent No.: 7,658,913 B2, 2010)
3. Rowe, V., Compositions Useful for Reducing Nephrotoxicity and Methods of Use Thereof. (Divisional, Publication No.: US 2010/093664, Patent Pending)
4. Rowe, V., Compositions Useful for Reducing Toxicity Associated with Gadolinium- based Contrast Agents. (Publication No.: US 2009/0155181, Granted, awaiting No.)
5. Rowe, V., Methods for Reducing Cisplatin Nephrotoxicity. (Continuation, Publication No.: 2011/0027390, Patent Pending)
6. Rowe, V., Methods for Reducing Methotrexate Nephrotoxicity. (Continuation, Publication No.: 2011/0028413, Patent Pending)